Nuwellis
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow system...
Latest News
21 days ago · globenewswire.com
Nuwellis Announces Acceptance of Multicenter Pediatric Aquadex Study in Pediatric NephrologyULTRA-Peds Registry evaluated 91 pediatric patients across seven leading children's hospitals, providing important clinical evidence which the Company intends to use to support its proposed label expansion of Aquadex's indication to patients weighing 5 kg and above ULTRA-Peds Registry evaluated 91 pediatric patients across seven leading children's hospitals, providing important clinical evidence which the Company intends to use to support its proposed label expansion of Aquadex's indication to patients weighing 5 kg and above
1 month ago · globenewswire.com
Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT SystemMINNEAPOLIS, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced that it will convene a Medical & Nursing Advisory Board on November 18–19, 2026, to support the continued development of Vivian™, the Company's next-generation pediatric continuous renal replacement therapy (CRRT) platform. Vivian is under development for children as small as 2.5kg and it incorporates multiple fluid management therapies in one platform.
2 months ago · globenewswire.com
Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical ConferencesMINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced its participation in four leading medical conferences in October spanning pediatrics, critical care, and heart failure. Across the events, Nuwellis will engage directly with clinicians on the challenge of fluid overload and the role of its Aquadex SmartFlow® system in providing precise, controlled fluid removal for patients who require individualized fluid management.
2 months ago · globenewswire.com
Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue OpportunityYear-to-date console sales exceed full-year console sales in seven of the past 10 years, putting Nuwellis on pace for one of its strongest years in console placements Year-to-date console sales exceed full-year console sales in seven of the past 10 years, putting Nuwellis on pace for one of its strongest years in console placements
2 months ago · globenewswire.com
Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory AffairsExperienced medical device quality and regulatory leader brings 13 years of experience supporting quality systems, regulatory compliance, audits and product development Experienced medical device quality and regulatory leader brings 13 years of experience supporting quality systems, regulatory compliance, audits and product development
2 months ago · globenewswire.com
Nuwellis Advances Financial Efficiency Strategy with Improved Gross MarginsMINNEAPOLIS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, highlights continued progress under its financial efficiency strategy, including significant gross margin improvement, sustained product quality and supply performance, and further optimization of its cost structure.
3 months ago · globenewswire.com
Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility MedicalAgreement expands Nuwellis' pediatric and critical care portfolio and provides a milestone-based pathway to U.S. distribution Agreement expands Nuwellis' pediatric and critical care portfolio and provides a milestone-based pathway to U.S. distribution
3 months ago · seekingalpha.com
Nuwellis, Inc. (NUWE) Q2 2026 Earnings Call Prepared Remarks TranscriptNuwellis, Inc. (NUWE) Q2 2026 Earnings Call Prepared Remarks Transcript
Earnings
Add to Watchlist
Select watchlists to add or remove NUWE